The Use of Biologics During the COVID-19 Pandemic

被引：15
作者：
Jones, Madison E. [1 ]
Kucharik, Alison H. [2 ]
Pourali, Sarah P. [3 ]
Rajkumar, Jeffrey R. [4 ]
Gutierrez, Yasmin [5 ]
Yim, Rebecca M. [1 ]
Armstrong, April W. [1 ]
机构：
[1] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90089 USA
[2] Florida Atlantic Univ, Charles E Schmidt Coll Sci, 777 Glades Rd BC-71, Boca Raton, FL 33431 USA
[3] Vanderbilt Univ, Sch Med, 1161 21st Ave S D3300, Nashville, TN 37232 USA
[4] Univ Illinois, Coll Med, 1853 W Polk St, Chicago, IL 60612 USA
[5] Univ Calif Riverside, Sch Med, 92521 Bot Gardens Dr, Riverside, CA 92521 USA
来源：
DERMATOLOGIC CLINICS | 2021年 / 39卷 / 04期
关键词：
COVID-19; Biologics; Psoriasis; Atopic dermatitis; Hidradenitis suppurativa; TNF-Inhibitor; IL inhibitor; Dupilumab; PSORIASIS; RISK; THERAPY; ADALIMUMAB; TRIALS;
D O I：
10.1016/j.det.2021.05.010
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：545 / 553
页数：9
相关论文
共 27 条
  • [1] The risk of respiratory tract infections and interstitial lung disease with interleukin 12/23 and interleukin 23 antagonists in patients with autoimmune diseases: A systematic review and meta-analysis
    Akiyama, Shintaro
    Yamada, Akihiro
    Micic, Dejan
    Sakuraba, Atsushi
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 84 (03) : 676 - 690
  • [2] American Academy of Dermatology, 2020, GUID US IMM AG
  • [3] Pathophysiology, Clinical Presentation, and Treatment of Psoriasis A Review
    Armstrong, April W.
    Read, Charlotte
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (19): : 1945 - 1960
  • [4] Adalimumab for treatment of hidradenitis suppurativa during the COVID-19 pandemic: Safety considerations
    Blaszczak, Alecia
    Trinidad, John C. L.
    Cartron, Alexander M.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (01) : E31 - E31
  • [5] SARS-CoV-2 asymptomatic infection in a patient under treatment with dupilumab
    Caroppo, F.
    Biolo, G.
    Belloni Fortina, A.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (08) : E368 - E368
  • [6] Biologics increase the risk of SARS-CoV-2 infection and hospitalization, but not ICU admission and death: Real-life data from a large cohort during red-zone declaration
    Damiani, Giovanni
    Pacifico, Alessia
    Bragazzi, Nicola L.
    Malagoli, Piergiorgio
    [J]. DERMATOLOGIC THERAPY, 2020, 33 (05)
  • [7] European Academy of Dermatology and Venereology, 2020, SYST THER PAT HIDR S
  • [8] Safety of dupilumab in severe atopic dermatitis and infection of Covid-19: two case reports
    Ferrucci, S.
    Romagnuolo, M.
    Angileri, L.
    Berti, E.
    Tavecchio, S.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (07) : E303 - E304
  • [9] COVID-19 in a patient with severe chronic rhinosinusitis with nasal polyps during therapy with dupilumab
    Foerster-Ruhrmann, Ulrike
    Szczepek, Agnieszka J.
    Bachert, Claus
    Olze, Heidi
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 146 (01) : 218 - 220
  • [10] National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1
    Gelfand, Joel M.
    Armstrong, April W.
    Bell, Stacie
    Anesi, George L.
    Blauvelt, Andrew
    Calabrese, Cassandra
    Dommasch, Erica D.
    Feldman, Steve R.
    Gladman, Dafna
    Kircik, Leon
    Lebwohl, Mark
    Lo Re, Vincent, III
    Martin, George
    Merola, Joseph F.
    Scher, Jose U.
    Schwartzman, Sergio
    Treat, James R.
    Van Voorhees, Abby S.
    Ellebrecht, Christoph T.
    Fenner, Justine
    Ocon, Anthony
    Syed, Maha N.
    Weinstein, Erica J.
    Smith, Jessica
    Gondo, George
    Heydon, Sue
    Koons, Samantha
    Ritchlin, Christopher T.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : 1704 - 1716
123